Fulgent Genetics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
45.00
|
|
Average Rating
|
3.67
|
|
# Strong Buys
|
0
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.05
|
0.32
|
0.27
|
540.00%
|
|
2022-06-30
|
0.73
|
0.78
|
0.05
|
6.85%
|
|
2022-03-31
|
3.86
|
5.08
|
1.22
|
31.61%
|
|
2021-12-31
|
2.61
|
3.34
|
0.73
|
27.97%
|
|
2021-09-30
|
3.25
|
3.93
|
0.68
|
20.92%
|
|
2021-06-30
|
2.76
|
2.59
|
-0.17
|
-6.16%
|
|
2021-03-31
|
5.86
|
6.52
|
0.66
|
11.26%
|
|
2020-12-31
|
4.06
|
6.20
|
2.14
|
52.71%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
6.18
|
|
2021-12-31
|
16.38
|
|
2020-12-31
|
8.42
|
|
2019-12-31
|
0.18
|
|
2018-12-31
|
-0.11
|
|
2017-12-31
|
-0.03
|
|
2016-12-31
|
0.15
|